Viruses

Certain tilapia families have been shown to be completely resistant to tilapia lake virus (TiLV), offering hope that breeding programmes can combat one of the worst diseases to hit the global fish farming industry in rec…

Infectious salmon anaemia (ISA) has been discovered at one of Cermaq’s salmon sites in the far south of Chile.

A new study outlines the seven viral infections (other than tilapia lake virus) that can affect tilapia farms and profiles the steps the industry can take to tackle viral outbreaks.

Three new viruses – including one type that has never previously infected fish – have been identified in populations of both wild and farmed salmon off the coast of British Columbia, Canada.

Texan shrimp producer NaturalShrimp has announced that its facility in La Coste is no longer under quarantine for infectious haematopoietic virus (IHHNV).

The first confirmed case of tilapia lake virus (TiLV) in the USA emphasises the need for producers to ensure biosecurity is a top priority, according to a leading US tilapia breeder.

Salmon farmers can hope to reduce the number of mortalities caused by cardiomyopathic syndrome (CMS), following the discovery of genetic markers that should allow the production of salmon strain that are more resistant t…

Mediterranean sea bass and sea bream farmers are being invited to join an online discussion focusing on viral encelophaty and retinopathy (VER), which causes viral nervous necrosis (VNN), on the MedAID Health Forum next …

A new project that aims to speed up the development of a strain of salmon with higher tolerance against the infectious salmon anaemia virus (ISAV) starts next month in Norway.

Early harvest of fish diagnosed with infectious salmon anaemia cost Norway Royal Salmon (NRS) in the region of NOK 55 million (£5 million) in the final quarter of 2017.

The conclusions of a recently published paper that links the transfer of the piscine orthoreovirus (PRv) from farm-raised salmon to wild salmon have been questioned by the BC Salmon Farmers Association (BCSFA).

On 1 November 2017, the Norwegian Medicines Agency granted Pharmaq authorisation to produce viral antigens at their new facility in Kløfta. The site has the capacity to produce several hundred million vaccine doses per a…

The UK’s kelp biofuel industry is being urged to watch out for viruses, following the results a ground-breaking study.

A virulent strain of the ISA virus has been detected in salmon broodstock at AquaGen’s Merraberget sea site and Rimstad land facility.